Quantbot Technologies LP Paratek Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.67 - $2.51 $1,503 - $2,259	900 Added 15.79%	6,600 $12,000
Q2 2022 Aug 09, 2022	BUY	$1.73 - $3.09 $5,536 - $9,888	3,200 Added 128.0%	5,700 $11,000
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $3,822 - $6,200	1,300 Added 108.33%	2,500 $7,000
Q4 2021 Feb 11, 2022	BUY	$4.07 - $5.3 $4,477 - $5,830	1,100 Added 1100.0%	1,200 $5,000
Q3 2021 Nov 09, 2021	SELL	$4.7 - $7.24 $19,237 - $29,633	-4,093 Reduced 97.62%	100 $0
Q2 2021 Aug 12, 2021	BUY	$6.81 - $10.93 $28,554 - $45,829	4,193 New	4,193 $28,000
Q4 2020 Feb 12, 2021	SELL	$4.58 - $7.14 $47,054 - $73,356	-10,274 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.19 - $6.69 $43,048 - $68,733	10,274 New	10,274 $55,000
Q1 2018 May 11, 2018	SELL	$12.65 - $18.85 $14,496 - $21,602	-1,146 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$17.45 - $25.6 $113,477 - $166,476	-6,503 Reduced 85.02%	1,146 $20,000
Q3 2017 Nov 07, 2017	BUY	$18.9 - $28.2 $144,566 - $215,701	7,649	7,649 $191,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.